CEO Albert Bourla said earlier this week that he doesn’t agree with pharma critics who say COVID-19 vaccine developers should forgo profits on products they make to address the crisis.
“You need to be very fanatic and radical to say something like that right now,” he told Barron’s. “Who is finding the solution? The private sector,” he added.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,